Akiram Therapeutics announced that it has raised SEK 68 million in a round of funding led by new investor Sciety AB on January 12, 2023. The transaction included participation from new investor Linc AB invested SEK 20 million through shares.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
73.7 SEK | +5.29% | +8.38% | +14.09% |
Apr. 22 | Linc AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Jan. 25 | Linc AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+14.09% | 394M | |
-7.04% | 158M | |
+2.49% | 141M |
- Stock Market
- Equities
- LINC Stock
- News Linc AB
- Akiram Therapeutics AB announced that it has received SEK 68 million in funding from Sciety AB, Linc AB